Formulation and evaluation of xanthan gum based aceclofenac tablets for colon targeted drug delivery

被引:29
作者
Ramasamy, Thiruganesh [2 ,4 ]
Kandhasami, Uma Devi Subbaih [1 ,3 ]
Ruttala, Himabindhu [4 ]
Shanmugam, Suresh [1 ]
机构
[1] Vels Univ, Dept Pharmaceut, Sch Pharmaceut Sci, Madras 600117, Tamil Nadu, India
[2] Utah Inha DDS & Adv Therapeut Res Ctr, Dept Bioengn & Regenerat Med, Inchon, South Korea
[3] Raos Coll Pharm, Dept Pharmaceut, Nellore, India
[4] Pydah Coll Pharm, Dept Pharmaceut, Kakinada, India
关键词
Drugs/release colon targeted; Aceclofenac/release colon targeted; Xanthan gum; Colon targeting; Eudragit coating; In vitro dissolution; Targeted delivery; IN-VITRO; DICLOFENAC SODIUM; MATRIX TABLET; RELEASE; OSTEOARTHRITIS; IBUPROFEN; SYSTEMS; DESIGN;
D O I
10.1590/S1984-82502011000200011
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The objective of the present study is to develop a colon targeted drug delivery systems for Aceclofenac using xanthan gum as a carrier. In this study, multilayer coated system that is resistant to gastric and small intestinal conditions but can be easily degraded by colonic bacterial enzymes was designed to achieve effective colon delivery of Aceclofenac. The xanthan gum, the drug and the physical mixture were characterized by Fourier transform infrared spectroscopy (FTIR) and differential scanning calorimetry (DSC). All the formulations were evaluated for hardness, drug content uniformity and other physical properties. Release aspects of Aceclofenac in simulated gastrointestinal fluid and colonic fluid with enzymes were investigated. From these results, Eudragit coated system exhibited gastric and small intestinal resistance to the release of Aceclofenac. The rapid increase in release of Aceclofenac in SCF was revealed as due to the degradation of the xanthan gum membrane by bacterial enzymes. The designed system could be used potentially as a carrier for colon delivery of Aceclofenac by regulating drug release in stomach and the small intestine.
引用
收藏
页码:299 / 311
页数:13
相关论文
共 49 条
[1]  
Akanksha T, 2009, INT J PHARM CLIN RES, V1, P43
[2]  
[Anonymous], NSAIDS RHEUMATOID AR
[3]  
[Anonymous], 2010, Int J Pharmtech Res
[4]  
[Anonymous], 1999, US PHARMACOPOEIA, P587
[5]  
[Anonymous], 2004, US PHARMACOPOEIA, P2300
[6]  
[Anonymous], 2008, US PHARMACOPOEIA
[7]  
Aulton ME, 1988, PHARM SCI DOSAGE FOR, P247
[8]   Design and evaluation of matrix-based controlled release tablets of diclofenac sodium and chondroitin sulphate [J].
Avachat, Amelia ;
Kotwal, Vikram .
AAPS PHARMSCITECH, 2007, 8 (04)
[9]  
Bi YX, 1996, CHEM PHARM BULL, V44, P2121
[10]  
Carr R.L., 1965, Chem. Eng, V72, P163, DOI DOI 10.1016/J.JAEROSCI.2007.10.003